Potassium 1-carboxyvinyl hydrogen phosphate

Modify Date: 2024-01-02 10:59:47

Potassium 1-carboxyvinyl hydrogen phosphate Structure
Potassium 1-carboxyvinyl hydrogen phosphate structure
Common Name Potassium 1-carboxyvinyl hydrogen phosphate
CAS Number 4265-07-0 Molecular Weight 206.132
Density N/A Boiling Point 466.7ºC at 760 mmHg
Molecular Formula C3H4KO6P Melting Point 175 °C (dec.)(lit.)
MSDS Chinese USA Flash Point 236.1ºC

 Names

Name Phospho(enol)pyruvic acid monopotassium salt
Synonym More Synonyms

 Chemical & Physical Properties

Boiling Point 466.7ºC at 760 mmHg
Melting Point 175 °C (dec.)(lit.)
Molecular Formula C3H4KO6P
Molecular Weight 206.132
Flash Point 236.1ºC
Exact Mass 205.938263
PSA 116.70000
LogP 0.13220
Storage condition −20°C

 MSDS

Name: Phosphoenolpyruvic Acid Monopotassium Salt 99% Material Safety Data Sheet
Synonym: PEP
CAS: 4265-07-0
Section 1 - Chemical Product MSDS Name:Phosphoenolpyruvic Acid Monopotassium Salt 99% Material Safety Data Sheet
Synonym:PEP

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
4265-07-0 Phosphoenolpyruvic Acid, Monopotassium 99% 224-247-0
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a tightly closed container. Keep refrigerated. (Store below 4C/39F.)

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 4265-07-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 175.00 - 179.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C3H4O6PK
Molecular Weight: 206.13

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 4265-07-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Phosphoenolpyruvic Acid, Monopotassium Salt - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 4265-07-0: 1
Canada
CAS# 4265-07-0 is listed on Canada's NDSL List.
CAS# 4265-07-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 4265-07-0 is listed on the TSCA inventory.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Safety Phrases S24/25
RIDADR NONH for all modes of transport
WGK Germany 3
HS Code 2931900090

 Synthetic Route

~%

Potassium 1-carboxyvinyl hydrogen phosphate Structure

Potassium 1-car...

CAS#:4265-07-0

Literature: Hirschbein, Bernard L.; Mazenod, Francois P.; Whitesides, George M. Journal of Organic Chemistry, 1982 , vol. 47, # 19 p. 3765 - 3766

 Precursor & DownStream

Precursor  1

DownStream  1

 Customs

HS Code 2931900090
Summary 2931900090. other organo-inorganic compounds. VAT:17.0%. Tax rebate rate:13.0%. Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward). MFN tariff:6.5%. General tariff:30.0%

 Articles4

More Articles
Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.

Mol. Neurobiol. 48(1) , 49-61, (2013)

Glycogen, the largest cytosolic macromolecule, is soluble because of intricate construction generating perfect hydrophilic-surfaced spheres. Little is known about neuronal glycogen function and metabo...

Rapid clonal growth and serial passage of human diploid fibroblasts in a lipid-enriched synthetic medium supplemented with epidermal growth factor, insulin, and dexamethasone.

Proc. Natl. Acad. Sci. U. S. A. 78(9) , 5588-92, (1981)

A serum-free, hormone-supplemented medium, enriched with a mixture of lipids, has been developed that supports rapid clonal growth of human diploid fetal lung fibroblasts (Flow 2000, WI-38, MRC-5, and...

Alcoholic liver disease and the mitochondrial ribosome: methods of analysis.

Methods Mol. Biol. 447 , 381-94, (2008)

Chronic alcohol consumption has been shown to severely compromise mitochondrial protein synthesis. Hepatic mitochondria isolated from alcoholic animals contain decreased levels of respiratory complexe...

 Synonyms

2-Propenoic acid, 2-(phosphonooxy)-, potassium salt (1:1)
potassium,1-carboxyethenyl hydrogen phosphate
PEP monopotassium salt,PEP-K,Phospho(enol)pyruvate potassium salt
EINECS 224-247-0
MFCD00044476
mono-Potassium phosphoenolpyruvate
2-Propenoic acid, 2-(phosphonooxy)-, monopotassium salt
PHOSPHOENOLPYRUVIC ACID MONOPOTASSIUM SALT
2-(Phosphonooxy)-2-propenoic acid monopotassium sal
Potassium 1-carboxyvinyl hydrogen phosphate
Potassium 1-carboxyvinyl hydrogenphosphate